Tilray Brands Posts $210 Million in Quarterly Revenue, Returns to Profitability

Tilray Brands has reported record first quarter fiscal 2026 results, achieving $210 million in net revenue and posting net income of $1.5 million.

The company says the performance underscores its focus on profitability and operational efficiency, with adjusted EBITDA climbing 9% year-over-year to $10.2 million. Cash flow from operations also improved significantly, narrowing to a $1.3 million outflow compared to $35.3 million a year earlier.

The quarter ended August 31, 2025, saw strong gains across Tilray’s business segments. Canadian adult-use cannabis revenue increased 12%, maintaining the company’s lead position in the market. International cannabis sales grew 10% compared to the same period last year, while distribution revenue rose to $74 million, up from $68.1 million. Wellness products edged up slightly to $15.2 million. Beverage revenue was essentially flat at $55.7 million.

Despite lower gross margins across several categories, the company highlighted notable financial improvements. Tilray cut net debt down to just $4 million and now holds nearly $265 million in cash, providing flexibility for future strategic opportunities. Adjusted net income reached $3.9 million, a turnaround from a $6.1 million adjusted net loss last year.

Chief Executive Officer Irwin Simon said the results reflect Tilray’s long-term strategy of balancing growth with disciplined execution. He pointed to potential opportunities from U.S. cannabis rescheduling and expanding markets in Europe as areas where Tilray is well-positioned to grow.

Tilray reaffirmed its fiscal 2026 outlook, projecting adjusted EBITDA in the range of $62 million to $72 million. The company says it remains committed to expanding market share in cannabis while advancing its global beverage and wellness platforms.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here.

More articles from The Marijuana Herald:

Rhode Island Lawmakers File Bill to Create “RICare” Universal Healthcare System, Ban Premiums and Copays

Rhode Island Lawmakers File Bill to Create “RICare” Universal Healthcare System, Ban Premiums and Copays

CBD May Help Limit the “Second Wave” of Brain Damage After Traumatic Brain Injury, Study Finds

CBD May Help Limit the “Second Wave” of Brain Damage After Traumatic Brain Injury, Study Finds

CB1 Activation Helps Speed Wound Healing, Reports Study

CB1 Activation Helps Speed Wound Healing, Reports Study

Florida Senate Committee to Vote Feb. 18 on Bill Tightening Low-THC Marijuana Rules and Expanding Buffer Zones for Dispensaries

Florida Senate Committee to Vote Feb. 18 on Bill Tightening Low-THC Marijuana Rules and Expanding Buffer Zones for Dispensaries

Study: CBD Kills Rare Ovarian Tumor Cells by Targeting TRPV2 Channel and Mitochondrial Pathway

Study: CBD Kills Rare Ovarian Tumor Cells by Targeting TRPV2 Channel and Mitochondrial Pathway

Edible Hemp Film Helped Keep Freeze-Dried Berries Fresher in Storage, Study Finds

Edible Hemp Film Helped Keep Freeze-Dried Berries Fresher in Storage, Study Finds

Maryland Cannabis Industry Generates $98.9 Million in Sales in January, Prices down 12% from January 2025

Maryland Cannabis Industry Generates $98.9 Million in Sales in January, Prices down 12% from January 2025

Utah Committee Advances Bill to Allow Medical Marijuana Telehealth Recommendations, Expand Low-THC Products in Pharmacies

Utah Committee Advances Bill to Allow Medical Marijuana Telehealth Recommendations, Expand Low-THC Products in Pharmacies

New York Bill Would Let Liquor Stores Sell Low-THC Cannabis Beverages, Taxed at 9% Wholesale and 13% Retail

New York Bill Would Let Liquor Stores Sell Low-THC Cannabis Beverages, Taxed at 9% Wholesale and 13% Retail

U.S. Congress: Legislation to End Cannabis Prohibition Nationwide and Allow Expungements Gains Sponsors from Nearly 30 States and D.C.

U.S. Congress: Legislation to End Cannabis Prohibition Nationwide and Allow Expungements Gains Sponsors from Nearly 30 States and D.C.

Bipartisan Oregon Bill Would Allow Physician-Supervised Ibogaine Treatment

Bipartisan Oregon Bill Would Allow Physician-Supervised Ibogaine Treatment

Virginia Bill to Require Hospitals to Allow Medical Marijuana for Terminally Ill Patients Approved by Committee

Virginia Bill to Require Hospitals to Allow Medical Marijuana for Terminally Ill Patients Approved by Committee

Tilray Expands UK Medical Supply Network Through New Distribution Deal With Smartway Pharmaceuticals

Tilray Expands UK Medical Supply Network Through New Distribution Deal With Smartway Pharmaceuticals

Virginia House Appropriations Committee Advances Bill to Legalize Recreational Cannabis Sales 16 to 6

Virginia House Appropriations Committee Advances Bill to Legalize Recreational Cannabis Sales 16 to 6

New York Legislature Passes Bill Allowing Marijuana Dispensaries Near Houses of Worship, Sends Measure to Governor

New York Legislature Passes Bill Allowing Marijuana Dispensaries Near Houses of Worship, Sends Measure to Governor

Florida Appeals Court Upholds State’s THC Limits on Hemp Products

Florida Appeals Court Upholds State’s THC Limits on Hemp Products

U.S. Congress: Legislation to Prevent Cannabis Businesses From Taking Tax Deductions Following Rescheduling Gains 15th Sponsor

U.S. Congress: Legislation to Prevent Cannabis Businesses From Taking Tax Deductions Following Rescheduling Gains 15th Sponsor

New York Senate Committee Advances Bill Allowing Parolees and Probationers to Work in Legal Marijuana Industry

New York Senate Committee Advances Bill Allowing Parolees and Probationers to Work in Legal Marijuana Industry